Interleukin-15 (recombinant)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Interleukin-15 (recombinant), covering 2025-12-03 to 2025-12-03. Get the full timeline:
Most recent: Clinical Trial Update: Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers [Phase 1]